1,209
Views
9
CrossRef citations to date
0
Altmetric
Review Article

Disease of the Year: Differential Diagnosis of Uveitic Macular Edema

ORCID Icon, , ORCID Icon &
Pages 72-88 | Received 25 May 2018, Accepted 10 Sep 2018, Published online: 01 Oct 2018

References

  • Fardeau C, Champion E, Massamba N, LeHoang P. Uveitic macular edema. Eye Lond Engl. 2016;30(10):1277–1292. doi:10.1038/eye.2016.115.
  • Thurau SR. [Cystoid macular edema in uveitis]. Ophthalmol Z Dtsch Ophthalmol Ges. 2005;102(5):485–490. doi:10.1007/s00347-005-1183-9.
  • de Smet MD, Okada AA. Cystoid macular edema in uveitis. Dev Ophthalmol. 2010;47:136–147. doi:10.1159/000320077.
  • Cunha-Vaz J, Coscas G. Diagnosis of macular edema. Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Augenheilkd. 2010;224(Suppl 1):2–7. doi:10.1159/000315156.
  • Gupta V, Al-Dhibi HA, Arevalo JF. Retinal imaging in uveitis. Saudi J Ophthalmol Off J Saudi Ophthalmol Soc. 2014;28(2):95–103. doi:10.1016/j.sjopt.2014.02.008.
  • Bazvand F, Zarei M, Ebrahimiadib N, et al. Ocular manifestations, conventional fundus fluorescein angiographic findings, and relationship between angiographic findings and visual acuity in Behçet’s disease. Semin Ophthalmol. 2017;32(6):764–771.doi:10.1080/08820538.2016.1178310.
  • Kim M, Kwon HJ, Choi EY, Kim SS, Koh HJ, Lee SC. Correlation between fluorescein angiographic findings and visual acuity in Behçet retinal vasculitis. Yonsei Med J. 2015;56(4):1087–1096. doi:10.3349/ymj.2015.56.4.1087.
  • Thomas AS, Redd T, Campbell JP, et al. The impact and implication of peripheral vascular leakage on ultra-widefield fluorescein angiography in uveitis. Ocul Immunol Inflamm. October 2017;1–7. doi:10.1080/09273948.2017.1367406.
  • Karampelas M, Sim DA, Chu C, et al. Quantitative analysis of peripheral vasculitis, ischemia, and vascular leakage in uveitis using ultra-widefield fluorescein angiography. Am J Ophthalmol. 2015;159(6):1161–1168.e1.doi:10.1016/j.ajo.2015.02.009.
  • Mesquida M, Llorenç V, Fontenla JR, Navarro MJ, Adán A. Use of ultra-wide-field retinal imaging in the management of active Behçet retinal vasculitis. Retina Phila Pa. 2014;34(10):2121–2127. doi:10.1097/IAE.0000000000000197.
  • Chi Y, Guo C, Peng Y, Qiao L, Yang L. A prospective, observational study on the application of ultra-wide-field angiography in the evaluation and management of patients with anterior uveitis. PloS One. 2015;10(3):e0122749. doi:10.1371/journal.pone.0122749.
  • Campbell JP, Leder HA, Sepah YJ, et al. Wide-field retinal imaging in the management of noninfectious posterior uveitis. Am J Ophthalmol. 2012;154(5):908–911.e2.doi:10.1016/j.ajo.2012.05.019.
  • Markomichelakis NN, Halkiadakis I, Pantelia E, et al. Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography. Ophthalmology. 2004;111(5):946–953.doi:10.1016/j.ophtha.2003.08.037.
  • Grewal DS, O’Sullivan ML, Kron M, Jaffe GJ. Association of disorganization of retinal inner layers with visual acuity in eyes with uveitic cystoid macular edema. Am J Ophthalmol. 2017;177:116–125. doi:10.1016/j.ajo.2017.02.017.
  • Roesel M, Henschel A, Heinz C, Dietzel M, Spital G, Heiligenhaus A. Fundus autofluorescence and spectral domain optical coherence tomography in uveitic macular edema. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol. 2009;247(12):1685–1689. doi:10.1007/s00417-009-1149-8.
  • Tran THC, de Smet MD, Bodaghi B, Fardeau C, Cassoux N, Lehoang P. Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography. Br J Ophthalmol. 2008;92(7):922–927. doi:10.1136/bjo.2007.136846.
  • Antcliff RJ, Stanford MR, Chauhan DS, et al. Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology. 2000;107(3):593–599.
  • Mitkova-Hristova VT, Konareva-Kostianeva MI, Balian AM, Stoyanova NS, Semerdzhieva MA. Discrepancies between spectral domain optical coherence tomography and fluorescein angiography in detecting uveitic macular edema. Folia Med (Plovdiv). 2015;57(3–4):207–215. doi:10.1515/folmed-2015-0040.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature (sun) working group. standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
  • Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 2005;50(4):364–388. doi:10.1016/j.survophthal.2005.04.003.
  • D’Ambrosio EM, La Cava M, Tortorella P, Gharbiya M, Campanella M, Iannetti L. Clinical features and complications of the HLA-B27-associated acute anterior uveitis: a Metanalysis. Semin Ophthalmol. 2017;32(6):689–701. doi:10.3109/08820538.2016.1170158.
  • Chee S-P, Bacsal K, Jap A, S-Y S-T, Cheng CL, Tan BH. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol. 2008;145(5):834–840. doi:10.1016/j.ajo.2007.12.015.
  • Tugal-Tutkun I, Otük-Yasar B, Altinkurt E. Clinical features and prognosis of herpetic anterior uveitis: a retrospective study of 111 cases. Int Ophthalmol. 2010;30(5):559–565. doi:10.1007/s10792-010-9394-8.
  • Al-Mansour YS, Al-Rajhi AA, Al-Dhibi H, Abu El-Asrar AM. Clinical features and prognostic factors in Fuchs’ uveitis. Int Ophthalmol. 2010;30(5):501–509. doi:10.1007/s10792-010-9379-7.
  • M-L B, Kim SJ, Thorne JE, et al. Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography. Am J Ophthalmol. 2009;148(1):128–135.e2.doi:10.1016/j.ajo.2009.02.029.
  • Llop SM, Papaliodis GN. Cataract Surgery complications in uveitis patients: A review article. Semin Ophthalmol. 2018;33(1):64–69. doi:10.1080/08820538.2017.1353815.
  • Okhravi N, Lightman S. Cystoid macular edema in uveitis. Ocul Immunol Inflamm. 2003;11:29–38.
  • Kotaniemi K, Penttila H. Intraocular lens implantation in patients with juvenile idiopathic arthritis-associated uveitis. Ophthalmic Res. 2006;38(6):318–323. doi:10.1159/000096225.
  • Bonfioli AA, Damico FM, Curi ALL, Orefice F. Intermediate uveitis. Semin Ophthalmol. 2005;20(3):147–154. doi:10.1080/08820530500232035.
  • Babu BM, Rathinam SR. Intermediate uveitis. Indian J Ophthalmol. 2010;58(1):21–27. doi:10.4103/0301-4738.58469.
  • Paović J, Paović P, Vukosavljević M. Clinical and immunological features of retinal vasculitis in systemic diseases. Vojnosanit Pregl. 2009;66:961–965.
  • Androudi S, Dastiridou A, Symeonidis C, et al. Retinal vasculitis in rheumatic diseases: an unseen burden. Clin Rheumatol. 2013;32(1):7–13.doi:10.1007/s10067-012-2078-1.
  • Rosenbaum JT, Sibley CH, Lin P. Retinal vasculitis. Curr Opin Rheumatol. 2016;28(3):228–235. doi:10.1097/BOR.0000000000000271.
  • Agarwal A, Karkhur S, Aggarwal K, et al. Epidemiology and clinical features of inflammatory retinal vascular occlusions: pooled data from two tertiary-referral institutions. Clin Experiment Ophthalmol. 2018;46(1):62–74.doi:10.1111/ceo.12997.
  • Mir TA, Reddy AK, Burkholder BM. et al. Clinical features and incidence rates of ocular complications in patients with retinal vasculitis. Am J Ophthalmol. 2017;179:171–178. doi:10.1016/j.ajo.2017.05.007.
  • Agarwal A, Afridi R, Agrawal R, Do DV, Gupta V, Nguyen QD. Multimodal imaging in retinal vasculitis. Ocul Immunol Inflamm. 2017;25(3):424–433. doi:10.1080/09273948.2017.1319494.
  • Agarwal A, Handa S, Aggarwal K, et al. The role of dexamethasone implant in the management of tubercular uveitis. Ocul Immunol Inflamm. November 2017;1–9. doi:10.1080/09273948.2017.1400074.
  • Gunasekeran DV, Agrawal R, Agarwal A, et al. the collaborative ocular tuberculosis study (cots)-1: a multinational review of 251 patients with tubercular retinal vasculitis. Retina Phila Pa. April 2018. doi:10.1097/IAE.0000000000002194.
  • Kaçmaz RO, Kempen JH, Newcomb C, et al. Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol. 2008;146(6):828–836.doi:10.1016/j.ajo.2008.06.019.
  • Knickelbein JE, Tucker W, Kodati S, Akanda M, Sen HN. Non-invasive method of monitoring retinal vasculitis in patients with birdshot chorioretinopathy using optical coherence tomography. Br J Ophthalmol. August 2017. doi:10.1136/bjophthalmol-2016-309837.
  • Bonfioli AA, Sarcoidosis OF. Semin Ophthalmol. 2005;20(3):177–182. doi:10.1080/08820530500231938.
  • Jovanović SV, Jovanović ZD, Radotić FM, Srećković SB, Paunović SS, Stojanović JD. Clinical aspects of posterior uveitis in ocular sarcoidosis. Acta Clin Croat. 2012;51:247–253.
  • Sudharshan S, Ganesh SK, Biswas J. Current approach in the diagnosis and management of posterior uveitis. Indian J Ophthalmol. 2010;58(1):29–43. doi:10.4103/0301-4738.58470.
  • Maenz M, Schlüter D, Liesenfeld O, Schares G, Gross U, Pleyer U. Ocular toxoplasmosis past, present and new aspects of an old disease. Prog Retin Eye Res. 2014;39:77–106. doi:10.1016/j.preteyeres.2013.12.005.
  • Shah KH, Levinson RD, Yu F, et al. Birdshot chorioretinopathy. Surv Ophthalmol. 2005;50(6):519–541.doi:10.1016/j.survophthal.2005.08.004.
  • Davis JL. Ocular syphilis. Curr Opin Ophthalmol. 2014;25(6):513–518. doi:10.1097/ICU.0000000000000099.
  • Gupta V, Gupta A, Rao NA. Intraocular tuberculosis – an update. Surv Ophthalmol. 2007;52(6):561–587. doi:10.1016/j.survophthal.2007.08.015.
  • Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada disease. Semin Ophthalmol. 2005;20(3):183–190. doi:10.1080/08820530500232126.
  • Spaide RF, Goldberg N, Freund KB. Redefining multifocal choroiditis and panuveitis and punctate inner choroidopathy through multimodal imaging. Retina Phila Pa. 2013;33(7):1315–1324. doi:10.1097/IAE.0b013e318286cc77.
  • Nazari Khanamiri H, Rao NA. Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis. Surv Ophthalmol. 2013;58(3):203–232. doi:10.1016/j.survophthal.2012.08.008.
  • Ahnood D, Madhusudhan S, Tsaloumas MD, Waheed NK, Keane PA, Denniston AK. Punctate inner choroidopathy: a review. Surv Ophthalmol. 2017;62(2):113–126. doi:10.1016/j.survophthal.2016.10.003.
  • Cornish KS, Williams GJ, Gavin MP, Imrie FR. Visual and optical coherence tomography outcomes of intravitreal bevacizumab and ranibizumab in inflammatory choroidal neovascularization secondary to punctate inner choroidopathy. Eur J Ophthalmol. 2011;21(4):440–445. doi:10.5301/EJO.2010.6117.
  • Invernizzi A, Agarwal AK, Ravera V, et al. Comparing optical coherence tomography findings in different aetiologies of infectious necrotising retinitis. Br J Ophthalmol. 2018;102(4):433–437.doi:10.1136/bjophthalmol-2017-310210.
  • Invernizzi A, Agarwal A, Ravera V, Oldani M, Staurenghi G, Viola F. Optical coherence tomography findings in cytomegalovirus retinitis: a longitudinal study. Retina Phila Pa. 2018;38(1):108–117. doi:10.1097/IAE.0000000000001503.
  • Neri P, Lettieri M, Fortuna C, Manoni M, Giovannini A. Inflammatory choroidal neovascularization. Middle East Afr J Ophthalmol. 2009;16(4):245–251. doi:10.4103/0974-9233.58422.
  • D’Ambrosio E, Tortorella P, Iannetti L. Management of uveitis-related choroidal neovascularization: from the pathogenesis to the therapy. J Ophthalmol. 2014;2014:450428. doi:10.1155/2014/450428.
  • Tugal-Tutkun I, Gupta V, Cunningham ET. Differential diagnosis of behçet uveitis. Ocul Immunol Inflamm. 2013;21(5):337–350. doi:10.3109/09273948.2013.795228.
  • Fardeau C, Lee CPL, Merle-Béral H, et al. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma. Am J Ophthalmol. 2009;147(5):886–894. 894e1. doi:10.1016/j.ajo.2008.12.025.
  • Sims J. Scleritis: presentations, disease associations and management. Postgrad Med J. 2012;88(1046):713–718. doi:10.1136/postgradmedj-2011-130282.
  • Akpek EK, Thorne JE, Qazi FA, Do DV, Jabs DA. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004;111(3):501–506. doi:10.1016/j.ophtha.2003.06.006.
  • Bernauer W, Pleisch B, Brunner M. Five-year outcome in immune-mediated scleritis. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol. 2014;252(9):1477–1481. doi:10.1007/s00417-014-2696-1.
  • Pavesio CE, Meier FM. Systemic disorders associated with episcleritis and scleritis. Curr Opin Ophthalmol. 2001;12:471–478.
  • Bainbridge J, Herbert E, Gregor Z. Macular holes: vitreoretinal relationships and surgical approaches. Eye Lond Engl. 2008;22(10):1301–1309. doi:10.1038/eye.2008.23.
  • Oh H. Idiopathic macular hole. Dev Ophthalmol. 2014;54:150–158. doi:10.1159/000360461.
  • Ip MS, Baker BJ, Duker JS, et al. Anatomical outcomes of surgery for idiopathic macular hole as determined by optical coherence tomography. Arch Ophthalmol Chic Ill 1960. 2002;120(1):29–35.
  • Smiddy WE, Flynn HW. Pathogenesis of macular holes and therapeutic implications. Am J Ophthalmol. 2004;137(3):525–537. doi:10.1016/j.ajo.2003.12.011.
  • Ac H, Dr G, Sl F. Macular hole. Surv Ophthalmol. 1998;42:393–416.
  • Di Antonio L, Toto L, Carpineto P, Mastropasqua A, De Nicola C, Mastropasqua L. Macular pseudohole development after sustained-release dexamethasone intravitreal implant for macular edema due to central retinal vein occlusion. Eur J Ophthalmol. 2014;24(1):134–137. doi:10.5301/ejo.5000317.
  • Lecleire-Collet A, Offret O, Gaucher D, Audren F, Haouchine B, Massin P. Full-thickness macular hole in a patient with diabetic cystoid macular oedema treated by intravitreal triamcinolone injections. Acta Ophthalmol Scand. 2007;85(7):795–798. doi:10.1111/j.1600-0420.2007.00925.x.
  • Unoki N, Nishijima K, Kita M, et al. Lamellar macular hole formation in patients with diabetic cystoid macular edema. Retina Phila Pa. 2009;29(8):1128–1133.doi:10.1097/IAE.0b013e3181a4d2d9.
  • De Benedetto U, Battaglia Parodi M, Knutsson KA, Lattanzio R, Bandello F, Iacono P. Macular hole after injection of dexamethasone intravitreal implant for macular oedema due to central retinal vein occlusion. Acta Ophthalmol (Copenh). 2013;91(1):e75–77. doi:10.1111/j.1755-3768.2012.02484.x.
  • Erdurman FC, Pellumbi A, Durukan AH. Lamellar macular hole formation in a patient with diabetic CME treated by intravitreal bevacizumab injections. Ophthalmic Surg Lasers Imaging Off J Int Soc Imaging Eye. 2012;43 Online:e87–89. doi:10.3928/15428877-20120823-05.
  • Kempen JH. Drug-induced maculopathy. Int Ophthalmol Clin. 1999;39:67–82.
  • Li J, Tripathi RC, Tripathi BJ. Drug-induced ocular disorders. Drug Saf. 2008;31:127–141.
  • Halfeld Furtado de Mendonça R, Maia OO, Yukihiko Takahashi W. Electrophysiologic findings in chloroquine maculopathy. Doc Ophthalmol Adv Ophthalmol. 2007;115(2):117–119. doi:10.1007/s10633-007-9060-2.
  • Gualtieri W, Janula J. Topiramate maculopathy. Int Ophthalmol. 2013;33(1):103–106. doi:10.1007/s10792-012-9640-3.
  • Koh T, Baek S-H, Han JI, Kim US. Maculopathy associated with tacrolimus (FK 506). Korean J Ophthalmol KJO. 2011;25(1):69–71. doi:10.3341/kjo.2011.25.1.69.
  • Pinto R, Vila-Franca M, Oliveira Afonso C, Ornelas C, Santos L. Ritonavir and bull’s eye maculopathy: case report. GMS Ophthalmol Cases. 2013;3. doi:10.3205/oc000011.
  • Doshi RR, Fortun JA, Kim BT, Dubovy SR, Rosenfeld PJ. Pseudocystic foveal cavitation in tamoxifen retinopathy. Am J Ophthalmol. 2014;157(6):1291–1298.e3. doi:10.1016/j.ajo.2014.02.046.
  • Kasturi N, Srinivasan R. Clofazimine-induced premaculopathy in a vitiliginous patient. J Pharmacol Pharmacother. 2016;7(3):149–151. doi:10.4103/0976-500X.189685.
  • Mason JO, Patel SA. Bull’S eye maculopathy in a patient taking sertraline. Retin Cases Brief Rep. 2015;9(2):131–133. doi:10.1097/ICB.0000000000000115.
  • Gelman R, Kiss S, Tsang SH. Multimodal imaging in a case of deferoxamine-induced maculopathy. Retin Cases Brief Rep. 2014;8(4):306–309. doi:10.1097/ICB.0000000000000059.
  • Tunc M. Maculopathy following extended usage of clomiphene citrate. Eye Lond Engl. 2014;28(9):1144–1146. doi:10.1038/eye.2014.121.
  • Joshi MM, Garretson BR. Paclitaxel maculopathy. Arch Ophthalmol Chic Ill 1960. 2007;125(5):709–710. doi:10.1001/archopht.125.5.709.
  • Fonollosa A, Mesquida M, Adan A. Uveitic macular oedema after treatment with vemurafenib. Acta Ophthalmol (Copenh). 2015;93(8):e686–687. doi:10.1111/aos.12678.
  • Choe CH, McArthur GA, Caro I, Kempen JH, Amaravadi RK. Ocular toxicity in BRAF mutant cutaneous melanoma patients treated with vemurafenib. Am J Ophthalmol. 2014;158(4):831–837.e2. doi:10.1016/j.ajo.2014.07.003.
  • Shields MK, Adler PA, Fuzzard DRW, Chalasani R, Teong JMY A. Case of acute bilateral Irvine-Gass syndrome following uncomplicated phacoemulsification, demonstrated with optical coherence tomography. Case Rep Ophthalmol. 2015;6(1):143–148. doi:10.1159/000430087.
  • Singh R, Alpern L, Jaffe GJ. et al. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clin Ophthalmol Auckl NZ. 2012;6:1259–1269. doi:10.2147/OPTH.S31902.
  • Irvine SR. A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol. 1953;36:599–619.
  • Munk MR, Jampol LM, Simader C, et al. Differentiation of diabetic macular edema from pseudophakic cystoid macular edema by spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2015;56(11):6724–6733.doi:10.1167/iovs.15-17042.
  • McCafferty S, Harris A, Kew C, et al. Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo. BMC Ophthalmol. 2017;17(1):16.doi:10.1186/s12886-017-0405-7.
  • Medić A, Jukić T, Matas A, Vukojević K, Sapunar A, Znaor L. Effect of preoperative topical diclofenac on intraocular interleukin-12 concentration and macular edema after cataract surgery in patients with diabetic retinopathy: a randomized controlled trial. Croat Med J. 2017;58:49–55.
  • Kim SJ, Belair M-L, Bressler NM, et al. A method of reporting macular edema after cataract surgery using optical coherence tomography. Retina Phila Pa. 2008;28(6):870–876.doi:10.1097/IAE.0b013e318169d04e.
  • Flach AJ. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc. 1998;96:557–634.
  • Lobo CL, Faria PM, Soares MA, Bernardes RC, Cunha-Vaz JG. Macular alterations after small-incision cataract surgery. J Cataract Refract Surg. 2004;30(4):752–760. doi:10.1016/S0886-3350(03)00582-0.
  • Sotirchos ES, Saidha S, Byraiah G, et al. In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology. 2013;80(15):1406–1414.doi:10.1212/WNL.0b013e31828c2f7a.
  • Balk LJ, Killestein J, Polman CH, Uitdehaag BMJ, Petzold A. Microcystic macular oedema confirmed, but not specific for multiple sclerosis. Brain J Neurol. 2012;135(Pt12):e226. doi:10.1093/brain/aws216.authorreplye227.
  • Sigler EJ, Randolph JC, Charles S. Delayed onset inner nuclear layer cystic changes following internal limiting membrane removal for epimacular membrane. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol. 2013;251(7):1679–1685. doi:10.1007/s00417-012-2253-8.
  • JMB de B G, Dlc I, MP de Á. Dexamethasone 0.7 mg implants in the management of pseudophakic cystoid macular edema. Arq Bras Oftalmol. 2016;79(2):113–115. doi:10.5935/0004-2749.20160033.
  • Ohsugi H, Ikuno Y, Ohara Z, et al. Changes in choroidal thickness after cataract surgery. J Cataract Refract Surg. 2014;40(2):184–191.doi:10.1016/j.jcrs.2013.07.036.
  • Noda Y, Ogawa A, Toyama T, Ueta T. Long-term increase in subfoveal choroidal thickness after surgery for senile cataracts. Am J Ophthalmol. 2014;158(3):455–459.e1. doi:10.1016/j.ajo.2014.05.016.
  • Pierru A, Carles M, Gastaud P, Baillif S. Measurement of subfoveal choroidal thickness after cataract surgery in enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci. 2014;55(8):4967–4974. doi:10.1167/iovs.14-14172.
  • Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina Phila Pa. 2011;31(3):510–517.doi:10.1097/IAE.0b013e3181eef053.
  • Nakayama M, Keino H, Okada AA, et al. Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease. Retina Phila Pa. 2012;32(10):2061–2069.doi:10.1097/IAE.0b013e318256205a.
  • Kim M, Kim H, Kwon HJ, Kim SS, Koh HJ, Lee SC. Choroidal thickness in Behcet’s uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes. Invest Ophthalmol Vis Sci. 2013;54(9):6033–6039. doi:10.1167/iovs.13-12231.
  • Fardeau C, Tran THC, Gharbi B, Cassoux N, Bodaghi B, LeHoang P. Retinal fluorescein and indocyanine green angiography and optical coherence tomography in successive stages of Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007;27(2–3):163–172. doi:10.1007/s10792-006-9024-7.
  • Bouchenaki N, Herbort CP. The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease. Ophthalmology. 2001;108:54–64.
  • Chu CJ, Johnston RL, Buscombe C, et al. Risk factors and incidence of macular edema after cataract surgery: a database study of 81984 eyes. Ophthalmology. 2016;123(2):316–323.doi:10.1016/j.ophtha.2015.10.001.
  • Shorstein NH, Liu L, Waxman MD, Herrinton LJ. Comparative effectiveness of three prophylactic strategies to prevent clinical macular edema after phacoemulsification surgery. Ophthalmology. 2015;122(12):2450–2456. doi:10.1016/j.ophtha.2015.08.024.
  • Mathys KC, Cohen KL. Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema. Eye Lond Engl. 2010;24(1):90–96. doi:10.1038/eye.2009.10.
  • Tsilimbaris MK, Tsika C, Kymionis GD. Intravitreal ketorolac for the treatment of chronic cystoid macular edema after cataract surgery. Ther Clin Risk Manag. 2016;12:177–182. doi:10.2147/TCRM.S97342.
  • Yüksel B, Uzunel UD, Kerci SG, Sağban L, Küsbeci T, Örsel T. Comparison of subtenon triamcinolone acetonide injection with topical nepafenac for the treatment of pseudophakic cystoid macular edema. Ocul Immunol Inflamm. 2017;25(4):513–519. doi:10.3109/09273948.2016.1147587.
  • Boscia F, Giancipoli E, D’Amico Ricci G, Pinna A. Management of macular oedema in diabetic patients undergoing cataract surgery. Curr Opin Ophthalmol. 2017;28(1):23–28. doi:10.1097/ICU.0000000000000328.
  • Donnenfeld ED, Holland EJ, Solomon KD, et al. A multicenter randomized controlled fellow eye trial of pulse-dosed difluprednate 0.05% versus prednisolone acetate 1% in cataract surgery. Am J Ophthalmol. 2011;152(4):609–617.e1.doi:10.1016/j.ajo.2011.03.018.
  • Baartman BJ, Gans R, Goshe J. Prednisolone versus dexamethasone for prevention of pseudophakic cystoid macular edema. Can J Ophthalmol J Can Ophtalmol. 2018;53(2):131–134. doi:10.1016/j.jcjo.2017.08.012.
  • Hudes GR, Li WY, Rockey JH, White P. Prostacyclin is the major prostaglandin synthesized by bovine retinal capillary pericytes in culture. Invest Ophthalmol Vis Sci. 1988;29:1511–1516.
  • Shelsta HN, Jampol LM. Pharmacologic therapy of pseudophakic cystoid macular edema: 2010 update. Retina Phila Pa. 2011;31(1):4–12. doi:10.1097/IAE.0b013e3181fd9740.
  • Conway MD, Canakis C, Livir-Rallatos C, Peyman GA. Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg. 2003;29:27–33.
  • Simone JN, Whitacre MM. Effects of anti-inflammatory drugs following cataract extraction. Curr Opin Ophthalmol. 2001;12:63–67.
  • Kim SJ, Flach AJ, Jampol LM. Nonsteroidal anti-inflammatory drugs in ophthalmology. Surv Ophthalmol. 2010;55(2):108–133. doi:10.1016/j.survophthal.2009.07.005.
  • Benhamou N, Massin P, Haouchine B, Audren F, Tadayoni R, Gaudric A. Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol. 2003;135:246–249.
  • Bellocq D, Korobelnik J-F, Burillon C, et al. Effectiveness and safety of dexamethasone implants for post-surgical macular oedema including Irvine-Gass syndrome: the EPISODIC study. Br J Ophthalmol. 2015;99(7):979–983.doi:10.1136/bjophthalmol-2014-306159.
  • Ghasemi Falavarjani K, Parvaresh -M-M, Modarres M, Hashemi M, Samiy N. Intravitreal bevacizumab for pseudophakic cystoid macular edema; a systematic review. J Ophthalmic Vis Res. 2012;7:235–239.
  • Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404(6779):787–790.doi:10.1038/35008121.
  • Leal EC, Manivannan A, Hosoya K-I, et al. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2007;48(11):5257–5265.doi:10.1167/iovs.07-0112.
  • Zheng L, Gong B, Hatala DA, Kern TS. Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Invest Ophthalmol Vis Sci. 2007;48(1):361–367. doi:10.1167/iovs.06-0510.
  • Coscas G, De Benedetto U, Coscas F, et al. Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Augenheilkd. 2013;229(1):32–37.doi:10.1159/000342159.
  • Madeira MH, Boia R, Santos PF, Ambrósio AF, Santiago AR. Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases. Mediators Inflamm. 2015;2015:673090. doi:10.1155/2015/673090.
  • Block ML, Hong J-S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol. 2005;76(2):77–98. doi:10.1016/j.pneurobio.2005.06.004.
  • Vujosevic S, Bini S, Midena G, Berton M, Pilotto E, Midena E. Hyperreflective intraretinal spots in diabetics without and with nonproliferative diabetic retinopathy: an in vivo study using spectral domain OCT. J Diabetes Res. 2013;2013:491835. doi:10.1155/2013/491835.
  • Pang CE, Messinger JD, Zanzottera EC, Freund KB, Curcio CA. The onion sign in neovascular age-related macular degeneration represents cholesterol crystals. Ophthalmology. 2015;122(11):2316–2326. doi:10.1016/j.ophtha.2015.07.008.
  • Cunha-Vaz JG, Travassos A. Breakdown of the blood-retinal barriers and cystoid macular edema. Surv Ophthalmol. 1984;28:Suppl:485–492.
  • Pelosini L, Hull CC, Boyce JF, McHugh D, Stanford MR, Marshall J. Optical coherence tomography may be used to predict visual acuity in patients with macular edema. Invest Ophthalmol Vis Sci. 2011;52(5):2741–2748. doi:10.1167/iovs.09-4493.
  • Sun JK, Lin MM, Lammer J, et al. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol. 2014;132(11):1309–1316.doi:10.1001/jamaophthalmol.2014.2350.
  • Moein H-R, Novais EA, Rebhun CB, et al. OPTICAL coherence tomography angiography to detect macular capillary ischemia in patients with inner retinal changes after resolved diabetic macular edema. Retina Phila Pa. October 2017. doi:10.1097/IAE.0000000000001902.
  • Spaide RF. Volume-rendered optical coherence tomography of diabetic retinopathy pilot study. Am J Ophthalmol. 2015;160(6):1200–1210. doi:10.1016/j.ajo.2015.09.010.
  • Gaudric A, Coscas G, Bird AC. Choroidal ischemia. Am J Ophthalmol. 1982;94:489–498.
  • Sagoo MS, Mehta H, Swampillai AJ, et al. Primary intraocular lymphoma. Surv Ophthalmol. 2014;59(5):503–516.doi:10.1016/j.survophthal.2013.12.001.
  • B-J C, Dy K, Uc P, Jy L, Yh Y, Hg Y. Clinical features and treatment outcomes of vitreoretinal lymphoma according to its association with cns lymphoma. Ocul Immunol Inflamm. 2018;26(3):365–371. doi:10.1080/09273948.2017.1421669.
  • Levasseur SD, Wittenberg LA, White VA. Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes. JAMA Ophthalmol. 2013;131(1):50–55. doi:10.1001/jamaophthalmol.2013.569.
  • Kim J, Chang W, Sagong M. Bilateral serous retinal detachment as a presenting sign of acute lymphoblastic leukemia. Korean J Ophthalmol KJO. 2010;24(4):245–248. doi:10.3341/kjo.2010.24.4.245.
  • Izzedine H, Fardeau C, Gauthier M, et al. Bilateral serous retinal detachment as a presenting sign of nephrotic syndrome. Intern Med Tokyo Jpn. 2014;53(22):2609–2613.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.